Navigation Links
New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management
Date:5/22/2012

SAN DIEGO, May 22, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the thirteen abstracts relating to its proprietary diagnostic platform presented at Digestive Disease Week (DDW) 2012.

The abstracts (see full list below) highlight Prometheus's innovative technologies aimed at helping healthcare providers personalize patient care with the goal of ultimately helping to improve patient outcomes.  Topics span across a wide spectrum of scientific and clinical research that offers novel solutions to current and future patient needs.  "We are proud to continue to lead the way toward personalized medicine. We are committed to continue to advance our novel technology platforms and partner with the GI community to help bring valuable products to market with the goal of continuing to improve patient outcomes," said Joseph M. Limber, President and Chief Executive Officer of Prometheus.

In the Feagan et al abstract, antibody-to-infliximab (ATI) levels proved highly predictive of disease activity, as measured by median C-reactive protein (CRP) concentrations - regardless of serum infliximab (IFX) levels.   Both ATI and IFX levels were measured using the novel Prometheus mobility shift assay among more than 1,487 samples from 532 participants in four prospective Crohn's disease randomized controlled trials.  CRP concentrations were higher among ATI positive patients with IFX levels < 3 ug/ml (8.4 vs. 5.65; p < 0.001) as well as IFX levels > 3 ug/ml (9.9 vs. 1.5; p < 0.01), as compared to ATI negative patients.

The development of these antibodies can shorten the duration of clinical response to IFX and decrease the likelihood of an IBD patient remaining in remission.

"Knowing exactly what factors contribute to a patient's loss of response to a biologic therapy is ideal for accurately and efficiently determining an appropriate c
'/>"/>

SOURCE Prometheus Laboratories Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
2. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
3. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
4. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
5. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
6. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
7. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
8. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
9. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
10. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
11. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery ... that it has raised A$19.3 million via a placement ... Europe , the U.S., Asia ... million from a share purchase plan (SPP) to be ... will be made in two tranches. "This ...
(Date:7/11/2014)... , July 11, 2014 ... to Safety & Health Expo 2014 were ... move to London , ... attending exhibition.          ... http://photos.prnewswire.com/prnh/20140711/696892-a )      (Photo: ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... Oct. 12 "The FDA,s just approved monthly drug treatment ... largest substance abuse treatment provider, CRC Health Group, Recovery Division ... country. Rhodes said the new treatment regimen "will provide addicts ... a new way to reduce or eliminate relapse. We are ...
... (NYSE: WPI ), a leading specialty pharmaceutical company, ... quarter 2010 financial results on Thursday, November 4, 2010 prior ... will also host a conference call and webcast at 8:30 ... its financial results and provide an update on the Company,s ...
Cached Medicine Technology:FDA's Just Approved Monthly Drug Treatment, Vivitrol Could Be 'Game Changer,' Says Country's Largest Drug Treatment Recovery President, CRC's Jerry Rhodes; Provides Addicts 'One Decision A Month Instead of 30' 2Watson to Host Conference Call and Webcast to Discuss Third Quarter 2010 Earnings 2
(Date:7/13/2014)... The North American water storage systems market ... $5,450 million by 2018, at a CAGR of 21.0%, from ... at a rapid pace in North America. The U.S. is ... water & wastewater storage and collection, and the increased spending ... expanding at a healthy rate in Canada, and is rising ...
(Date:7/13/2014)... 13, 2014 Advanced boilers are ... least amount of fossil fuels, produce high-capacity power, ... to increased global warming and climate change concerns, ... reduce harmful gas emissions and pollutants coming from ... in the global advance boilers market., The global ...
(Date:7/13/2014)... 2014 MarketsandMarkets recently conducted a ... 3D Scanning; 3D rendering; Layout and Animation; Image ... - 2018)”, which analyzes and studies the major ... Western Europe, Eastern Europe, Middle East and Africa, ... the competitive landscape of the 3D imaging market, ...
(Date:7/13/2014)... The Pearland, Texas location of The Little Gym, a gymnastics ... 12 years of age that offers everything from gymnastics, dance, ... Camps, is now under new ownership. , Kevin Berry comes ... over six years at The Little Gym of Bellaire in ... has over ten years of experience working with children, including ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special occasion dress manufacturer ... gorgeous Quinceanera dresses . , In ... outfits is huge. Therefore, 2014QuinceaneraDresses.com is striving to ... released dresses are made according to the latest ... , It is worthy of mention that ...
Breaking Medicine News(10 mins):Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2
... BEACH, Calif., Nov. 29 Diabetes Response,Service, the ... the United States and Canada December 1st, 2007 ... who monitor the subscribers to,prevent hypoglycemia and complications ... Diabetes Response Service provides customizable,scheduled text message reminders ...
... the More You Care About AIDS, World Vision ... ,Put a Face on the Pandemic, UNITED NATIONS, ... discovered, one-third of the people in seven wealthy nations,admit ... and AIDS epidemic,and one-fourth believe the problem is "greatly ...
... the female hormone , THURSDAY, Nov. 29 (HealthDay News) ... often given with estrogen in hormone replacement therapy -- ... say. , They conducted tests on female mice genetically ... this conclusion. , Treatment with estrogen blocked the Alzheimer,s-like ...
... Consortium Health to Create New, Database File Storage ... CAMPBELL, Calif., Nov. 29 ONStor Inc., the ... enterprise, today,announced that Consortium Health Plans, Inc., a ... Shield Plans, has chosen the ONStor,Bobcat Series NAS ...
... Administration (FDA) has accepted for filing the New, Drug ... therapy in the treatment of partial ... 29 UCB announced today that the U.S. Food,and ... Application,(NDA) for the use of lacosamide as adjunctive therapy ...
... Medco Health,Solutions, Inc. (NYSE: MHS ) today announced ... The stock split, effected in the form,of a dividend, will ... Jan. 10, 2008 to receive one additional share of Medco ... dividend will be,distributed on Jan. 24, 2008., Since becoming ...
Cached Medicine News:Health News:Diabetes Response Service Launches in U.S. and Canada 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 3Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 4Health News:Progesterone Won't Shield Women Against Alzheimer's 2Health News:Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStor's Green Clustered NAS Solution 2Health News:Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStor's Green Clustered NAS Solution 3Health News:UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy 2Health News:UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy 3Health News:Medco Announces Two-For-One Stock Split 2Health News:Medco Announces Two-For-One Stock Split 3Health News:Medco Announces Two-For-One Stock Split 4Health News:Medco Announces Two-For-One Stock Split 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: